glutathione liver function Frontiers The Biological Functions of Glutathione
Description
Many people are afraid of getting a vitamin B12 shot for fear of side effects

As most undesirable effects are based on post-marketing spontaneous reporting, frequency estimation is not possible. Immune system disorders Frequency not known: Hypersensitivity reactions, such as sweating, tachycardia, and skin reactions with itching and urticaria. Gastrointestinal disorders Less frequent: Gastrointestinal complaints, such as nausea, vomiting, diarrhoea and abdominal pain. Skin and subcutaneous tissue disorders Less frequent: Cases of acne or eczema have been reported after high doses of Vitamin B12. General disorders and administration site conditions Frequency not known: Injection site reactions. Renal and urinary disorders Less frequent: Chromaturia (reddish urine, appeared during the first 8 hours after an administration and typically resolves within 48 hours).Reporting of suspected adverse reactionsReporting suspected adverse reactions after authorisation of the medicine is important. It allows continued monitoring of the benefit/risk balance of the medicine. Health care providers are asked to report any suspected adverse reactions to SAHPRA via the 6.04 Adverse Drug Reactions Reporting Form, found online under SAHPRAs publications

Profiling the aqueous humor, including the metabolites it contains, is useful to understand physiological and pathological conditions in the eye

The mechanism of action primarily focuses on enhancing the bodys natural detoxification processes and reducing oxidative stress. Compared to other other forms of glutathione supplementation, injections offer superior bioavailability, ensuring that the full dose reaches cells without any degradation

The unique liposome structure allows it to combine effectively with the body's natural fluids and penetrate its protective membranes, bypassing the digestive system and directly entering the blood stream.* By avoiding the process of digestion, nutrient absorption and utilization is much quicker and more complete.

In vitro study using human vascular endothelial cells further confirmed the increased mRNA and protein expressions of VEGFR2 but not VEGF-A by BPC 157
